CK Life Sciences Int'l., (Holdings) Inc.

Informe acción SEHK:775

Capitalización de mercado: HK$4.4b

CK Life Sciences Int'l. (Holdings) Dirección

Dirección controles de criterios 2/4

El CEO de CK Life Sciences Int'l. (Holdings) es Lance Richard Lee Yuen, nombrado en Sep 2024, tiene una permanencia de menos de un año. posee directamente un 0.024% de las acciones de la empresa, con un valor de HK$1.06M. La antigüedad media del equipo directivo y de la junta directiva es de 14.2 años y 6 años, respectivamente.

Información clave

Lance Richard Lee Yuen

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEOn/a
Permanencia del CEOless than a year
Participación del CEO0.02%
Permanencia media de la dirección14.2yrs
Promedio de permanencia en la Junta Directiva6yrs

Actualizaciones recientes de la dirección

Recent updates

CK Life Sciences Int'l., (Holdings) Inc.'s (HKG:775) Share Price Boosted 34% But Its Business Prospects Need A Lift Too

Oct 04
CK Life Sciences Int'l., (Holdings) Inc.'s (HKG:775) Share Price Boosted 34% But Its Business Prospects Need A Lift Too

There's No Escaping CK Life Sciences Int'l., (Holdings) Inc.'s (HKG:775) Muted Revenues Despite A 32% Share Price Rise

May 03
There's No Escaping CK Life Sciences Int'l., (Holdings) Inc.'s (HKG:775) Muted Revenues Despite A 32% Share Price Rise

CK Life Sciences Int'l. (Holdings)'s (HKG:775) Anemic Earnings Might Be Worse Than You Think

Apr 25
CK Life Sciences Int'l. (Holdings)'s (HKG:775) Anemic Earnings Might Be Worse Than You Think

CK Life Sciences Int'l. (Holdings) (HKG:775) Use Of Debt Could Be Considered Risky

Mar 26
CK Life Sciences Int'l. (Holdings) (HKG:775) Use Of Debt Could Be Considered Risky

Here's Why CK Life Sciences Int'l. (Holdings) (HKG:775) Can Manage Its Debt Responsibly

Sep 27
Here's Why CK Life Sciences Int'l. (Holdings) (HKG:775) Can Manage Its Debt Responsibly

Does CK Life Sciences Int'l. (Holdings) (HKG:775) Have A Healthy Balance Sheet?

Sep 16
Does CK Life Sciences Int'l. (Holdings) (HKG:775) Have A Healthy Balance Sheet?

Estimating The Intrinsic Value Of CK Life Sciences Int'l., (Holdings) Inc. (HKG:775)

Aug 21
Estimating The Intrinsic Value Of CK Life Sciences Int'l., (Holdings) Inc. (HKG:775)

These 4 Measures Indicate That CK Life Sciences Int'l. (Holdings) (HKG:775) Is Using Debt Extensively

Apr 14
These 4 Measures Indicate That CK Life Sciences Int'l. (Holdings) (HKG:775) Is Using Debt Extensively

CK Life Sciences Int'l., (Holdings) Inc. (HKG:775) Delivered A Weaker ROE Than Its Industry

Mar 18
CK Life Sciences Int'l., (Holdings) Inc. (HKG:775) Delivered A Weaker ROE Than Its Industry

If You Had Bought CK Life Sciences Int'l. (Holdings) (HKG:775) Shares Five Years Ago You'd Have Earned 45% Returns

Feb 01
If You Had Bought CK Life Sciences Int'l. (Holdings) (HKG:775) Shares Five Years Ago You'd Have Earned 45% Returns

What Kind Of Shareholders Hold The Majority In CK Life Sciences Int'l., (Holdings) Inc.'s (HKG:775) Shares?

Jan 04
What Kind Of Shareholders Hold The Majority In CK Life Sciences Int'l., (Holdings) Inc.'s (HKG:775) Shares?

CK Life Sciences Int'l. (Holdings) (HKG:775) Has A Somewhat Strained Balance Sheet

Dec 09
CK Life Sciences Int'l. (Holdings) (HKG:775) Has A Somewhat Strained Balance Sheet

We Wouldn't Rely On CK Life Sciences Int'l. (Holdings)'s (HKG:775) Statutory Earnings As A Guide

Nov 18
We Wouldn't Rely On CK Life Sciences Int'l. (Holdings)'s (HKG:775) Statutory Earnings As A Guide

CEO

Lance Richard Lee Yuen (59 yo)

less than a year

Permanencia

Mr. Lance Richard Lee Yuen is Executive Director, Vice President & Chief Executive Officer of CK Life Sciences Int'l. (Holdings) Inc. from September 20, 2024. Mr. Yuen joined the Group in September 2024.M...


Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
Tzar Kuoi Li
Executive Chairman 22.6yrsHK$125.00k0.023%
HK$ 1.0m
Hing Lam Kam
President & Executive Director22.4yrsHK$2.58m0.065%
HK$ 2.9m
Edmond Tak Chuen IP
Senior VPno dataHK$1.60m0.023%
HK$ 1.0m
Kean Meng Toh
VP, Chief Scientific Officer & Executive Director6yrsHK$6.13msin datos
Lance Richard Lee Yuen
VP, CEO & Executive Directorless than a yearsin datos0.024%
HK$ 1.1m
Wun Lam Wong
Chief Financial Officerno datasin datossin datos
Pak To Wu
Chief Operating Officer of Global Operationsno datasin datossin datos
Yau Wong
Senior Manager of Human Resources & Administrationno datasin datossin datos
Ching Sze Chiu
General Counselno datasin datossin datos
Sze Ho
Vice President of Corporate Developmentno datasin datossin datos
Wai Che Tong Barnes
Chief Corporate Affairs Officerno datasin datossin datos
Eirene Yeung
Company Secretary22.8yrssin datossin datos

14.2yrs

Permanencia media

59.5yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de 775 es experimentado (14.2 años antigüedad media).


Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Tzar Kuoi Li
Executive Chairman 22.6yrsHK$125.00k0.023%
HK$ 1.0m
Hing Lam Kam
President & Executive Directorno dataHK$2.58m0.065%
HK$ 2.9m
Edmond Tak Chuen IP
Senior VPno dataHK$1.60m0.023%
HK$ 1.0m
Kean Meng Toh
VP, Chief Scientific Officer & Executive Director6yrsHK$6.13msin datos
Lance Richard Lee Yuen
VP, CEO & Executive Directorless than a yearsin datos0.024%
HK$ 1.1m
Eva Kwok
Independent Non-Executive Director22.4yrsHK$100.00k0.0021%
HK$ 92.0k
Keith Frankel
Co-Chairman of Vitaquest International LLCno datasin datossin datos
Peter Peace Tulloch
Non-Executive Director22.6yrsHK$75.00k0.011%
HK$ 482.8k
Ying Choi Yu
Deputy Chairmanless than a yearHK$14.79m0.023%
HK$ 1.0m
Kai Cheong Kwan
Independent Non-executive Director9.7yrsHK$155.00ksin datos
Donald Jeffrey Roberts
Independent Non-Executive Director4.3yrsHK$205.00ksin datos
Joseph Paul Tighe
Independent Non-Executive Director5.4yrsHK$205.00ksin datos

6.0yrs

Permanencia media

70yo

Promedio de edad

Junta con experiencia: La junta directiva de 775 se considera experimentada (6 años de antigüedad promedio).